MioDottore records 2.5 million bookings/month, over 8.5 million monthly visits to the portal, almost 300,000 doctors available on the platform and around 35,000 customers. As of 2015 with a team of 500 people, MioDottore is part of Docplanner group, a main international HealthTech entity, supported by leading VCs like Goldman Sachs, One Peak Partners, Point Nine and Target Global. It is currently a unicorn with over €450M of investments raised.
Cyborg Score Rationale
MioDottore holds dominant market position in Italy with scale (2.5M monthly bookings, ~300K doctors), backed by a well-funded international parent (Docplanner, unicorn status with €450M+). Strong revenue indicators and strategic investor backing support growth trajectory, though market concentration in Italy and exposure to European healthcare regulation present execution risks.
Top Insights
Dominant Italian market position with 2.5M monthly bookings and 300K+ healthcare professionals on platform
Part of Docplanner unicorn group valued at €450M+, operating in 13 countries with 2M+ health professionals globally